Impact of intracellular chloride concentration on cisplatin accumulation in sensitive and resistant GLC4 cells.
Resistance to cisplatin [cis-diamminedichloroplatinum(II), CDDP] chemotherapy is a major problem in the clinic. Understanding the molecular basis of the intracellular accumulation of CDDP and other platinum-based anticancer drugs is of importance in delineating the mechanism of resistance to these clinically important therapies. Different molecular mechanisms may coexist, but defective uptake of CDDP is one of the most consistently identified characteristics of cells selected for CDDP resistance. We have studied the impact of intracellular chloride concentration on platinum-based compound accumulation in the human GLC4, GLC4/CDDP, and K562 tumor cell lines. We show that (1) a decrease of intracellular chloride concentration yielded an increase of CDDP accumulation and vice versa and (2) the intracellular chloride concentration in GLC4/CDDP cells is higher than in sensitive cells, whereas CDDP accumulation shows the opposite behavior. The identification of chloride as a critical determinant of CDDP intracellular accumulation and the molecular mechanisms by which CDDP-resistant cells modulate chloride concentration may allow alternative therapeutic approaches. Our findings indicate that increase of intracellular chloride concentration may be a major determinant of CDDP resistance.
Salerno
Milena
M
Laboratoire de Biophysique Moléculaire Cellulaire et Tissulaire, UMR-CNRS 7033, UFR SMBH, Université Paris 13, Bobigny, France. milena.salerno@univ-paris13.fr
Yahia
Dalila
D
Dzamitika
Simplice
S
de Vries
Elisabeth
E
Pereira-Maia
Elene
E
Garnier-Suillerot
Arlette
A
D000970:Antineoplastic Agents / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology*; D049109:Cell Proliferation / Q000187:drug effects; D002712:Chlorides / Q000032:analysis / Q000378:metabolism*; D002945:Cisplatin / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology*; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D013997:Time Factors; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D002712:Chlorides; D002945:Cisplatin
J Membr Biol. 1996 Aug;152(3):217-22
8672083
Cancer Res. 1988 Dec 1;48(23):6803-7
2846161
J Inorg Biochem. 1990 Apr;38(4):327-45
2332767
J Biol Chem. 2004 Nov 5;279(45):46393-9
15326162
Cancer Res. 1987 Apr 1;47(7):1780-4
3028613
Cancer Cells. 1990 Feb;2(2):35-43
2204382
Anal Biochem. 1989 May 1;178(2):355-61
2751097
Am J Physiol. 1994 Dec;267(6 Pt 2):H2114-23
7810712
Drug Resist Updat. 2000 Jun;3(3):139-141
11498377
Drug Resist Updat. 2004 Aug-Oct;7(4-5):227-32
15533760
Mol Cancer Ther. 2004 Dec;3(12):1543-9
15634647
J Biol Chem. 1993 Sep 25;268(27):20116-25
8376370
J Bioenerg Biomembr. 2006 Feb;38(1):11-21
16732471
Nat Rev Cancer. 2007 Aug;7(8):573-84
17625587
Nat Rev Drug Discov. 2005 Apr;4(4):307-20
15789122
Ultrastruct Pathol. 2002 Sep-Oct;26(5):331-4
12396244
Biochem Pharmacol. 2007 Jan 15;73(2):298-307
17097621
Drug Metab Dispos. 2002 Dec;30(12):1378-84
12433807
J Androl. 1999 Jan-Feb;20(1):88-93
10100478
Eur J Cancer. 2003 Nov;39(17):2450-61
14602131
J Med Chem. 2005 Aug 11;48(16):5191-202
16078838
Mol Pharmacol. 2004 Oct;66(4):817-23
15229296
J Inorg Biochem. 2004 Oct;98(10):1607-13
15458823
J Biol Chem. 2004 May 14;279(20):20622-5
15010460
Clin Cancer Res. 2004 Oct 1;10(19):6744-9
15475465
J Biol Inorg Chem. 2003 Jul;8(6):626-34
12756611
Br J Cancer. 1993 Jun;67(6):1171-6
8512802
FEBS Lett. 1999 Aug 6;456(2):327-31
10456333
Cancer. 1982 Nov 15;50(10):2031-3
6889911
Cancer Chemother Pharmacol. 2006 Jan;57(1):84-90
16044341
Cancer Res. 1994 Jan 15;54(2):487-93
8275486
Mutat Res. 2001 Jul 1;478(1-2):23-43
11406167
Oncol Rep. 2001 Nov-Dec;8(6):1285-7
11605050
Biochem Pharmacol. 2007 May 1;73(9):1270-9
17234160
J Inorg Biochem. 1997 Feb 15;65(3):199-205
9025271
Ann Intern Med. 1977 Jun;86(6):803-12
326117
Cancer Res. 2007 May 15;67(10):4860-8
17510416
Blood. 1975 Mar;45(3):321-34
163658
J Gen Physiol. 1983 May;81(5):731-48
6864192
J Pharm Sci. 1999 Mar;88(3):319-26
10052990
Physiol Rev. 2000 Jan;80(1):211-76
10617769
J Cell Physiol. 2007 May;211(2):513-21
17186499
Hepatology. 1999 Jan;29(1):101-10
9862856
Science. 1995 Dec 15;270(5243):1842-5
8525382
Cancer Res. 2000 Mar 1;60(5):1312-6
10728692
Biophys J. 1989 Dec;56(6):1071-81
2482083
Free Radic Biol Med. 2001 Nov 15;31(10):1170-8
11705695
Biochem Pharmacol. 2004 Jul 15;68(2):283-91
15194000
Cancer Chemother Pharmacol. 2004 Mar;53(3):239-46
14648017
Drug Metab Dispos. 1995 Feb;23(2):178-84
7736908
In Vivo. 1999 Sep-Oct;13(5):375-83
10654189